Trial · NCT02153528
Adverse events40
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 40
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Cardiopulmonary failure | Cardiac disorders | Standard TB Treatment | 1 | 348 | |
| serious | Cardiopulmonary failure | Cardiac disorders | Double Rimfampicin | 1 | 353 | |
| serious | Abdominal pain | Gastrointestinal disorders | Standard TB Treatment | 1 | 348 | |
| serious | Abdominal pain | Gastrointestinal disorders | Double Rimfampicin | 0 | 353 | |
| serious | Vomiting | Gastrointestinal disorders | Standard TB Treatment | 2 | 348 | |
| serious | Vomiting | Gastrointestinal disorders | Double Rimfampicin | 0 | 353 | |
| serious | Asthenia | General disorders | Standard TB Treatment | 0 | 348 | |
| serious | Asthenia | General disorders | Double Rimfampicin | 1 | 353 | |
| serious | Hepatitis | Hepatobiliary disorders | Standard TB Treatment | 2 | 348 | |
| serious | Hepatitis | Hepatobiliary disorders | Double Rimfampicin | 1 | 353 | |
| serious | Jaundice | Hepatobiliary disorders | Standard TB Treatment | 4 | 348 | |
| serious | Jaundice | Hepatobiliary disorders | Double Rimfampicin | 5 | 353 | |
| serious | Alanine aminotransferase increased | Investigations | Standard TB Treatment | 5 | 348 | |
| serious | Alanine aminotransferase increased | Investigations | Double Rimfampicin | 2 | 353 | |
| serious | Decreased appetite | Metabolism and nutrition disorders | Standard TB Treatment | 1 | 348 | |
| serious | Decreased appetite | Metabolism and nutrition disorders | Double Rimfampicin | 1 | 353 | |
| serious | Adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Standard TB Treatment | 0 | 348 | |
| serious | Adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Double Rimfampicin | 1 | 353 | |
| serious | Gallbladder cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Standard TB Treatment | 0 | 348 | |
| serious | Gallbladder cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Double Rimfampicin | 1 | 353 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02153528/events